Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Merkel Cell × relatlimab × Clear all

Sponsor

Conditions

Melanoma 3 Advanced Cancer 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Cancer 1

Interventions

pembrolizumab 5 avelumab 4 Nivolumab 4 Ipilimumab 3 Radiotherapy 2 Radiosurgery 2 ALT-803 2 tremelimumab 1 talimogene laherparepvec 1 sapanisertib 1 poly ICLC 1 interferon gamma-1b 1 epacadostat 1 efineptakin alfa 1 durvalumab 1 cabozantinib 1 bempegaldesleukin 1 atezolizumab 1 Radiation Dose Hypofractionation 1 Radiation 1 Interferon-gamma 1 Interferon-beta 1 B7-H1 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡